Altria on Thursday wrote down the investment it made last December in Juul Labs by more than a third, an implicit recognition that the stake the cigarette giant took in the embattled vape company was among the most ill-timed in recent corporate history.
The $4.5 billion writedown gives Juul a new valuation of about $24 billion. Late last year, Altria paid nearly $13 billion for a 35 percent stake in Juul, just before Juul became the target of regulators, politicians, and health officials who blamed it for stoking a major spike in youth vaping.
In its earnings call, Altria said it would continue to support the leadership changes at Juul, which is now run by a former Altria executive, and planned layoffs that could reduce headcount by as much as 15 percent.
Earlier this week, Fidelity also cut the value of its Juul stake by nearly 50 percent. Juul had been part of Fidelity's Blue Chip Growth Fund. The fund reported that its Juul investment fell a whopping $352 million in September alone as the government's crackdown on flavored vape products ramped up and more reports surfaced of people dying from a mysterious vaping-related illness. None of those deaths ー 34 have been confirmed as of last week ー have been directly tied to Juul products. BuzzFeed also reported this week on an explosive lawsuit by a former Juul executive who alleges that the company shipped more than a million contaminated pods to customers. Juul has called that suit baseless.
Altria's major investment in Juul was the clearest indication that the big cigarette makers, facing a worldwide decline in smoking, saw their future in vaporized nicotine. Nearly a year later, that bet is anything but clear.
Walmart, which became the nation’s largest retailer by making low prices a priority, has found itself in a place it’s rarely been: Warning customers that prices will rise for goods ranging from bananas to car seats.
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
American businesses that rely on Chinese goods are reacting with muted relief after the U.S. and China agreed to pause their exorbitant tariffs on each other’s products for 90 days. Many companies delayed or canceled orders after President Donald Trump last month put a 145% tariff on items made in China. Importers still face relatively high tariffs, however, as well as uncertainty over what will happen in the coming weeks and months. The temporary truce was announced as retailers and their suppliers are looking to finalize their plans and orders for the holiday shopping season. They’re concerned a mad scramble to get goods onto ships will lead to bottlenecks and increased shipping costs.
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.
